Houston, TX, United States of America

Ningyang Zhang

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: The University of Texas System. Active years: 2023-2024.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Ningyang Zhang in Antibody Drug Conjugates

Introduction

Ningyang Zhang is an accomplished inventor based in Houston, TX. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of antibody drug conjugates. With a total of 2 patents, his work focuses on enhancing the efficacy of drug delivery systems.

Latest Patents

Ningyang Zhang's latest patents revolve around linkers for antibody drug conjugates. In one aspect, the present disclosure provides compounds of specific formulas, wherein the variables are defined in detail. Additionally, the disclosure includes methods for preparing these compounds. Furthermore, it presents antibody drug conjugates that incorporate the compounds, along with pharmaceutical compositions and methods of use for these innovative solutions.

Career Highlights

Ningyang Zhang is affiliated with the University of Texas System, where he continues to advance research in his field. His work has garnered attention for its potential to improve therapeutic outcomes in various medical applications.

Collaborations

Ningyang collaborates with notable colleagues such as Kyoji Tsuchikama and Yasuaki Anami. Their combined expertise contributes to the innovative research being conducted in the realm of antibody drug conjugates.

Conclusion

Ningyang Zhang's contributions to the field of pharmaceutical sciences through his patents on antibody drug conjugates highlight his role as a key innovator. His work not only advances scientific knowledge but also has the potential to significantly impact patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…